Say hello to MassDevice +3, a bite-sized view of the top three me d-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
The federal government can depose employees of Boston Scientific’s star-crossed Guidant subsidiary for a whistleblower lawsuit alleging violations of the False Claims Act, even as BSX can get its hands on Medicare documents.
Shares of ArthroCare were flat last week after the medical device company said it returned to profits for the 4th quarter and 2012, as investors waited for more clarity about ongoing U.S. Justice Dept. investigations.
Medical device companies should brace for some unintended consequences now that the Centers for Medicare & Medicaid Services rules on the Physician Payment Sunshine Act are set: the overhead costs associated with compliance were slighted in the government insurance agency’s reckoning.